What is Echopixel?
EchoPixel, Inc. operates at the intersection of advanced medical imaging and interactive software development. By enabling physicians to interact with 4D holograms derived from standard medical imaging, the company provides a digital twin of patient anatomy that significantly improves the understanding of complex 3D relationships. This FDA 510k cleared platform is specifically engineered to support structural and congenital heart programs, positioning EchoPixel as a critical infrastructure provider in modern surgical workflows. The company's ability to bridge the gap between raw diagnostic data and actionable clinical insights has established it as a high-authority player in the medical technology sector.
How much funding has Echopixel raised?
Echopixel has raised a total of $19.7M across 6 funding rounds:
Unspecified
$1M
Angel/Seed
$2.4M
Unspecified
$1.8M
Private Equity
$6M
Series A
$8.5M
Debt
$150K
Unspecified (2012): $1M, investors not publicly disclosed
Angel/Seed (2013): $2.4M, investors not publicly disclosed
Unspecified (2016): $1.8M supported by AutoTech Ventures and Aurus Capital
Private Equity (2017): $6M featuring Aurus and 180 Degree Capital Corp
Series A (2017): $8.5M backed by Aurus Capital, Intel Capital, Runa Capital, 180 Degree Capital Corp, Binomial Ventures, and LAM Research
Debt (2020): $150K with participation from PPP
Key Investors in Echopixel
Aurus Capital
Aurus Ventures is a leading venture investment firm in Spanish-speaking Latin America that leverages its robust network and experience to invest in high-performance entrepreneurial teams with global vision.
Intel Capital
A division of Intel, this firm invests in innovative startups targeting artificial intelligence, autonomous systems, and next-generation compute technologies to drive industry-wide transformation.
180 Degree Capital Corp
This firm specializes in identifying and investing in undervalued companies, employing a constructive activist approach to unlock hidden value and improve financial performance.
What's next for Echopixel?
With a history of sustained financial backing, EchoPixel is well-positioned to scale its footprint in the global healthcare market. The strategic deployment of capital will likely focus on expanding the clinical utility of its 4D interactive software and deepening its integration within hospital systems. As the company moves beyond its initial growth phases, the focus will shift toward broader adoption of its digital twin technology, potentially exploring new therapeutic areas beyond cardiology. The continued support from institutional investors suggests a long-term commitment to maintaining EchoPixel's competitive advantage in precision health and diagnostic visualization.
See full Echopixel company page
